The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation
Open accessAbstract
Intestinal microbes provide multicellular hosts with nutrients and confer resistance to infection. The delicate balance between pro- and anti-inflammatory mechanisms, essential for gut immune homeostasis, is affected by the composition of the commensal microbial community. Regulatory T cells (Treg cells) expressing transcription factor Foxp3 have a key role in limiting inflammatory responses in the intestine. Although specific members of the commensal microbial community have been found to potentiate the generation of anti-inflammatory Treg or pro-inflammatory T helper 17 (TH17) cells, the molecular cues driving this process remain elusive. Considering the vital metabolic function afforded by commensal microorganisms, we reasoned that their metabolic by-products are sensed by cells of the immune system and affect the balance between pro- and anti-inflammatory cells. We tested this hypothesis by exploring the effect of microbial metabolites on the generation of anti-inflammatory Treg cells. We found that in mice a short-chain fatty acid (SCFA), butyrate, produced by commensal microorganisms during starch fermentation, facilitated extrathymic generation of Treg cells. A boost in Treg-cell numbers after provision of butyrate was due to potentiation of extrathymic differentiation of Treg cells, as the observed phenomenon was dependent on intronic enhancer CNS1 (conserved non-coding sequence 1), essential for extrathymic but dispensable for thymic Treg-cell differentiation. In addition to butyrate, de novo Treg-cell generation in the periphery was potentiated by propionate, another SCFA of microbial origin capable of histone deacetylase (HDAC) inhibition, but not acetate, which lacks this HDAC-inhibitory activity. Our results suggest that bacterial metabolites mediate communication between the commensal microbiota and the immune system, affecting the balance between pro- and anti-inflammatory mechanisms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“butyrate is capable of inducing Treg differentiation and controlling inflammation (17, 23, 24, 87).”
From The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication (2020) · cites this paper as [23]
Experimental — accuracy not yet measuredIn the citing paper
“For instance, butyrate has been shown to restrict inflammation by promoting the differentiation of Treg cells and supporting the functions of regulatory B cells.706–708”
From Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases (2024) · cites this paper as [707]
In the citing paper
“These were shown to promote the expansion of Tregs, but they also seem to improve the function of effector T cells10–15.”
From Microbial short-chain fatty acids modulate CD8+ T cell responses and improve adoptive immunotherapy for cancer (2021) · cites this paper as [10]
In the citing paper
“SCFAs have context-dependent functions: they can promote the expansion of Treg cells and also improve effector T cell functions133–136.”
From Gut OncoMicrobiome Signatures (GOMS) as next-generation biomarkers for cancer immunotherapy (2023) · cites this paper as [133]
In the citing paper
“Pending further confirmation, these results suggest that SCFAs display context-dependent immune effects that range from the differentiation of Treg cells to the enhancement of effector T cell functions.”
From Melanoma and microbiota: Current understanding and future directions (2024) · cites this paper as [58]
In the citing paper
“In addition, both propionate and butyrate could act as histone deacetylase (HDAC) inhibitor [74–76], through which SCFA increased histone acetylation in the promoter and conserved non-coding sequence (CNS) regions of the Foxp3 locus, the master transcription factor and specific marker of suppressive Tregs [75].”
From Gut microbiota-mediated immunomodulation in tumor (2021) · cites this paper as [76]
In the citing paper
“emphasizing the importance of administration route and SCFA concentration for in vivo experiments (Arpaia et al., 2013).”
From Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System (2017) · cites this paper as Arpaia et al., 2013
In the citing paper
“Each of these functions operates independently, as numbers of cTregs in germ-free mice, which are starkly reduced in the absence of treatment, can be rescued by separate provision of acetate, propionate or butyrate (Arpaia et al., 2013; Smith et al., 2013).”
From Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System (2017) · cites this paper as Arpaia et al., 2013
In the citing paper
“Direct application of 50 mM butyrate by enema, however, did elicit an increase in cTregs”
From Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System (2017) · cites this paper as Arpaia et al., 2013
In the citing paper
“Conversely, the de novo differentiation of cTregs relies on HDAC inhibition in both DCs and T cells, which acetate does not promote (Arpaia et al., 2013; Furusawa et al., 2013).”
From Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System (2017) · cites this paper as Arpaia et al., 2013
In the citing paper
“acetate and propionate, but not butyrate, stimulate the expansion of pre-existing colonic Tregs (cTregs)”
From Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System (2017) · cites this paper as Arpaia et al., 2013
In the citing paper
“Arpaia et al. detected no significant changes at a concentration of 36 mM”
From Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System (2017) · cites this paper as Arpaia et al., 2013
In the citing paper
“likely because this lower quantity of butyrate was largely absorbed by the upper gastrointestinal tract before reaching the colon (Arpaia et al., 2013; Smith et al., 2013).”
From Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System (2017) · cites this paper as Arpaia et al., 2013
In the citing paper
“whereas propionate and butyrate, but not acetate, increase the de novo differentiation of naive T cells into Tregs (Arpaia et al., 2013; Furusawa et al., 2013; Singh et al., 2014; Smith et al., 2013).”
From Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System (2017) · cites this paper as Arpaia et al., 2013
In the citing paper
“A subset of colonic regulatory CD4+ T cells lack differentiation in GF mice resulting from the absence of bacterial consortia capable of fermenting dietary fiber into short-chain fatty acids (SCFAs).105–107”
From Interaction between microbiota and immunity in health and disease (2020) · cites this paper as [105]
In the citing paper
“In mice, intake of dietary carbohydrates,105 certain probiotics,140 artificial sweeteners141 and emulsifiers142 can modulate host immunity and inflammation, in part mediated by compositional changes of the gut microbiome.”
From Interaction between microbiota and immunity in health and disease (2020) · cites this paper as [105]
In the citing paper
“oral administration of SCFAs protected mice from T cell-induced colitis by inducing immunosuppressive Tregs [38-40].”
From Antibiotic-Induced Changes in the Intestinal Microbiota and Disease (2016) · cites this paper as [38]
In the citing paper
“SCFAs were present at reduced concentrations in the fecal pellets of GF or antibiotic-treated mice”
From Antibiotic-Induced Changes in the Intestinal Microbiota and Disease (2016) · cites this paper as [38]
In the citing paper
“three different laboratories have identified microbiota-derived SCFAs (particularly propionate and butyrate), to be responsible for Treg differentiation/accumulation [38-40].”
From Antibiotic-Induced Changes in the Intestinal Microbiota and Disease (2016) · cites this paper as [38]
In the citing paper
“and on DCs, conferring a higher capacity to drive naïve T cell differentiation into Tregs [38-40].”
From Antibiotic-Induced Changes in the Intestinal Microbiota and Disease (2016) · cites this paper as [38]
In the citing paper
“SCFAs were found to act directly on T cells via the receptor GPCR43, thus enhancing FoxP3 expression through DNA acetylation”
From Antibiotic-Induced Changes in the Intestinal Microbiota and Disease (2016) · cites this paper as [38]
In the citing paper
“In addition to butyrate, new-onset Treg generation in the periphery was enhanced by propionate (115).”
From Gut Microbiome as a Potential Factor for Modulating Resistance to Cancer Immunotherapy (2020) · cites this paper as [115]
In the citing paper
“Additionally, the mucosal immune system profoundly impacts gut barrier functions both in health and disease conditions, reviewed previously.48,179, 180, 181, 182, 183”
From Regulation of Intestinal Barrier Function by Microbial Metabolites (2021) · cites this paper as [179]
In the citing paper
“SCFAs promote the development of naive CD4+ T cells into regulatory T cells (31, 32), induce “tolerogenic” dendritic cells in the intestinal mucosa (33), and limit autoimmity (34, 35).”
From Respiratory viral infection-induced microbiome alterations and secondary bacterial pneumonia. (2018) · cites this paper as [32]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic T reg Cell Homeostasis
Smith, P. M., Howitt, M. R., Panikov, N., Michaud, M., Gallini, C. A., Bohlooly-Y, M., Glickman, J. N., & Garrett, W. S. (2013) · Science · doi:10.1126/science.1241165 · Cited by 5,413
Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria
Ivanov, I. I., Atarashi, K., Manel, N., Brodie, E. L., Shima, T., Karaoz, U., Wei, D., Goldfarb, K. C., Santee, C. A., Lynch, S. V., et al. (2009) · Cell · doi:10.1016/j.cell.2009.09.033 · Cited by 4,554
Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species
Atarashi, K., Tanoue, T., Shima, T., Imaoka, A., Kuwahara, T., Momose, Y., Cheng, G., Yamasaki, S., Saito, T., Ohba, Y., et al. (2011) · Science · doi:10.1126/science.1198469 · Cited by 3,752
Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43
Maslowski, K. M., Vieira, A. T., Ng, A., Kranich, J., Sierro, F., Yu, D., Schilter, H. C., Rolph, M. S., Mackay, F., Artis, D., et al. (2009) · Nature · doi:10.1038/nature08530 · Cited by 3,241
Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota
Atarashi, K., Tanoue, T., Oshima, K., Suda, W., Nagano, Y., Nishikawa, H., Fukuda, S., Saito, T., Narushima, S., Hase, K., et al. (2013) · Nature · doi:10.1038/nature12331 · Cited by 2,872
Regulatory T Cell Lineage Specification by the Forkhead Transcription Factor Foxp3
Fontenot, J. D., Rasmussen, J. P., Williams, L. M., Dooley, J., Farr, A. G., & Rudensky, A. Y. (2005) · Immunity · doi:10.1016/j.immuni.2005.01.016 · Cited by 2,302
Self-citationRound, J. L., & Mazmanian, S. K. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909122107 · Cited by 2,233
Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice
Kim, J. M., Rasmussen, J. P., & Rudensky, A. Y. (2006) · Nature Immunology · doi:10.1038/ni1428 · Cited by 1,827
Self-citationRole of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate
Zheng, Y., Josefowicz, S. Z., Chaudhry, A., Peng, X. P., Forbush, K. A., & Rudensky, A. Y. (2010) · Nature · doi:10.1038/nature08750 · Cited by 1,170
Self-citationPeripheral education of the immune system by colonic commensal microbiota
Lathrop, S. K., Bloom, S. M., Rao, S. M., Nutsch, K., Lio, C.-W., Santacruz, N., Peterson, D. A., Stappenbeck, T. S., & Hsieh, C.-S. (2011) · Nature · doi:10.1038/nature10434 · Cited by 1,034
Cited by
Sorted by citations
Items 601–700 of 1,027
Butyrate inhibit collagen-induced arthritis via Treg/IL-10/Th17 axis
Hui, W., Yu, D., Cao, Z., & Zhao, X. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.01.018 · Cited by 170
Pursuing Human-Relevant Gut Microbiota-Immune Interactions
Spencer, S. P., Fragiadakis, G. K., & Sonnenburg, J. L. (2019) · Immunity · doi:10.1016/j.immuni.2019.08.002 · Cited by 167
The Impact of Gut Microbiota Disorders on the Blood–Brain Barrier
Wei, T., Zhu, H., Feng, Y., Guo, R., & Wan, D. (2020) · Infection and Drug Resistance · doi:10.2147/idr.s254403 · Cited by 171
The role of short-chain fatty acids in inflammatory skin diseases
Xiao, X., Hu, X., Yao, J., Cao, W., Zou, Z., Wang, L., Qin, H., Zhong, D., Li, Y., Xue, P., et al. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1083432 · Cited by 183
The Microbiome and Food Allergy
Iweala, O. I., & Nagler‐Anderson, C. (2019) · Annual Review of Immunology · doi:10.1146/annurev-immunol-042718-041621 · Cited by 171
The interaction between the gut Microbiota and herbal medicines
An, X., Bao, Q. D., Di, S., Zhao, Y. C., Zhao, S., Zhang, H., Lian, F., & Tong, X. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109252 · Cited by 167
Fisher, S. A., Rahimzadeh, M., Brierley, C. K., Gration, B., Doree, C. J., Kimber, C., Cajide, A. P., Lamikanra, A., & Roberts, D. J. (2019) · PLoS ONE · doi:10.1371/journal.pone.0222313 · Cited by 162
Goblet cell associated antigen passages support the induction and maintenance of oral tolerance
Kulkarni, D. H., Gustafsson, J. K., Knoop, K. A., McDonald, K. G., Bidani, S. S., Davis, J. E., Floyd, A. N., Hogan, S. P., Hsieh, C., & Newberry, R. D. (2019) · Mucosal Immunology · doi:10.1038/s41385-019-0240-7 · Cited by 167
Westfall, S., Caracci, F., Zhao, D., Wu, Q.-L., Frolinger, T., Simon, J. E., & Pasinetti, G. M. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.10.013 · Cited by 164
Kandpal, M., Indari, O., Baral, B., Jakhmola, S., Tiwari, D., Bhandari, V., Pandey, R. K., Bala, K., Sonawane, A., & Jha, H. C. (2022) · Metabolites · doi:10.3390/metabo12111064 · Cited by 177
Gut Microbiota in Colorectal Cancer: Biological Role and Therapeutic Opportunities
Pandey, H., Tang, D. W. T., Wong, S. H., & Lal, D. (2023) · Cancers · doi:10.3390/cancers15030866 · Cited by 171
Gut microbiota trajectory in pediatric patients undergoing hematopoietic SCT
Biagi, E., Zama, D., Nastasi, C., Consolandi, C., Fiori, J., Rampelli, S., Turroni, S., Centanni, M., Severgnini, M., Peano, C., et al. (2015) · Bone Marrow Transplantation · doi:10.1038/bmt.2015.16 · Cited by 158
Gonzalez-Perez, G., Hicks, A. L., Tekieli, T. M., Radens, C. M., Williams, B. L., & Lamousé-Smith, E. S. N. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1502322 · Cited by 161
Tunçil, Y. E., Xiao, Y., Porter, N. T., Reuhs, B. L., Martens, E. C., & Hamaker, B. R. (2017) · mBio · doi:10.1128/mbio.01068-17 · Cited by 164
Luo, S., Wen, R., Wang, Q., Zhao, Z., Nong, F., Fu, Y., Huang, S., Chen, J., Zhou, L., & Luo, X. (2018) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2018.08.033 · Cited by 161
Gut Microbiota Dysbiosis and Increased Plasma LPS and TMAO Levels in Patients With Preeclampsia
Wang, J., Gu, X., Yang, J., Wei, Y., & Zhao, Y. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00409 · Cited by 161
The Influence of Gut Dysbiosis in the Pathogenesis and Management of Ischemic Stroke
Chidambaram, S. B., Rathipriya, A. G., Mahalakshmi, A. M., Sonali, S., Hediyal, T. A., Ray, B., Sunanda, T., Rungratanawanich, W., Kashyap, R. S., Qoronfleh, M. W., et al. (2022) · Cells · doi:10.3390/cells11071239 · Cited by 168
Role of dietary fiber in promoting immune health—An EAACI position paper
Venter, C., Meyer, R. W., Greenhawt, M., Pali‐Schöll, I., Nwaru, B. I., Roduit, C., Untersmayr, E., Adel‐Patient, K., Agache, I. O., Agostoni, C. V., et al. (2022) · Allergy · doi:10.1111/all.15430 · Cited by 166
Bacteroidetes Species Are Correlated with Disease Activity in Ulcerative Colitis
Nomura, K., Ishikawa, D., Okahara, K., Ito, S., Haga, K., Takahashi, M., Arakawa, A., Shibuya, T., Osada, T., Kuwahara-Arai, K., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10081749 · Cited by 150
The gut microbiome in food allergy
Zhao, W., Ho, H.-E., & Bunyavanich, S. (2019) · Annals of Allergy, Asthma & Immunology · doi:10.1016/j.anai.2018.12.012 · Cited by 160
Kanai∥, T., Mikami, Y., & Hayashi, A. (2015) · Journal of Gastroenterology · doi:10.1007/s00535-015-1084-x · Cited by 164
When pathogenic bacteria meet the intestinal microbiota
Rolhion, N., & Chassaing, B. (2016) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2015.0504 · Cited by 169
Regulatory T cell adaptation in the intestine and skin
Whibley, N., Tucci, A., & Powrie, F. M. (2019) · Nature Immunology · doi:10.1038/s41590-019-0351-z · Cited by 169
Visekruna, A., & Luu, M. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.703218 · Cited by 170
Cytokine Networks and T-Cell Subsets in Inflammatory Bowel Diseases
Chen, M. L., & Sundrud, M. S. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000714 · Cited by 162
Diet and microbiota in inflammatory bowel disease: The gut in disharmony
Rapozo, D. C. M., Bernardazzi, C., & de Souza, H. S. P. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i12.2124 · Cited by 169
Natural killer cells and regulatory T cells in early pregnancy loss
Sharma, S. (2014) · The International Journal of Developmental Biology · doi:10.1387/ijdb.140109ss · Cited by 158
Dysbiosis in gastrointestinal disorders
Chang, C., & Lin, H. C. (2016) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2016.02.001 · Cited by 163
The Microbiome, Timing, and Barrier Function in the Context of Allergic Disease
Wesemann, D. R., & Nagler‐Anderson, C. (2016) · Immunity · doi:10.1016/j.immuni.2016.02.002 · Cited by 165
Nastasi, C., Fredholm, S., Willerslev-Olsen, A., Hansen, M., Bonefeld, C. M., Geisler, C., Andersen, M. H., Ødum, N., & Woetmann, A. (2017) · Scientific Reports · doi:10.1038/s41598-017-15099-w · Cited by 166
Kim, Y., Keogh, J. B., & Clifton, P. M. (2017) · Nutrients · doi:10.3390/nu9111271 · Cited by 161
Chu, F., Shi, M., Lang, Y., Shen, D., Jin, T., Zhu, J., & Cui, L. (2018) · Mediators of Inflammation · doi:10.1155/2018/8168717 · Cited by 164
Therapeutic Potential of the Gut Microbiota in the Prevention and Treatment of Sepsis
Haak, B. W., Prescott, H. C., & Wiersinga, W. J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02042 · Cited by 163
A mechanism for expansion of regulatory T-cell repertoire and its role in self-tolerance
Feng, Y., van der Veeken, J., Shugay, M., Putintseva, E. V., Osmanbeyoglu, H. U., Dikiy, S., Hoyos, B. E., Moltedo, B., Hemmers, S., Treuting, P., et al. (2015) · Nature · doi:10.1038/nature16141 · Cited by 157
Self-citationPan, W.-H., Sommer, F., Falk-Paulsen, M., Ulas, T., Best, L., Fazio, A., Kachroo, P., Luzius, A., Jentzsch, M., Rehman, A., et al. (2018) · Genome Medicine · doi:10.1186/s13073-018-0534-5 · Cited by 157
Long term effect of gut microbiota transfer on diabetes development
Peng, J., Narasimhan, S., Marchesi, J. R., Benson, A. K., Wong, F. S., & Li, W. (2014) · Journal of Autoimmunity · doi:10.1016/j.jaut.2014.03.005 · Cited by 157
The Environment of Regulatory T Cell Biology: Cytokines, Metabolites, and the Microbiome
Hoeppli, R. E., Wu, D., Cook, L., & Levings, M. K. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00061 · Cited by 162
Attia, S. L., Versloot, C. J., Voskuijl, W. P., van Vliet, S. J., Giovanni, V. D., Zhang, L., Richardson, S. E., Bourdon, C., Netea, M. G., Berkley, J. A., et al. (2016) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.116.130518 · Cited by 158
Zeng, Q., Gong, J., Liu, X., Chen, C., Sun, X., Li, H., Zhou, Y., Cui, C., Wang, Y., Yang, Y., et al. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.104468 · Cited by 159
Microenvironmental Metabolism Regulates Antitumor Immunity
Ngwa, V. M., Edwards, D. N., Philip, M., & Chen, J. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-0617 · Cited by 156
Interactions between host genetics and gut microbiome in diabetes and metabolic syndrome
Ussar, S., Fujisaka, S., & Kahn, C. R. (2016) · Molecular Metabolism · doi:10.1016/j.molmet.2016.07.004 · Cited by 163
Bifidobacterium Abundance in Early Infancy and Vaccine Response at 2 Years of Age
Huda, M. N., Ahmad, S. M., Alam, J., Khanam, A., Kalanetra, K. M., Taft, D. H., Raqib, R., Underwood, M. A., Mills, D. A., & Stephensen, C. B. (2019) · PEDIATRICS · doi:10.1542/peds.2018-1489 · Cited by 157
He, H., Qin, Q., Xu, F., Chen, Y., Rao, S., Wang, C., Jiang, X., Lu, X., & Xie, C. (2023) · Science Advances · doi:10.1126/sciadv.adf3887 · Cited by 158
T cells in the control of organ-specific autoimmunity
Bluestone, J. A., Bour-Jordan, H., Cheng, M., & Anderson, M. (2015) · Journal of Clinical Investigation · doi:10.1172/jci78089 · Cited by 155
The impact of a helminth-modified microbiome on host immunity
Brosschot, T. P., & Reynolds, L. A. (2018) · Mucosal Immunology · doi:10.1038/s41385-018-0008-5 · Cited by 165
Infectious Threats, the Intestinal Barrier, and Its Trojan Horse: Dysbiosis
Iacob, S. A., & Iacob, D. G. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01676 · Cited by 158
Zou, F., Qiu, Y., Huang, Y., Zou, H., Xiao, C., Niu, Q., Luo, A., & Sun, J. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03880-9 · Cited by 162
Roles of Regulatory T Cells in Tissue Pathophysiology and Metabolism
Campbell, C., & Rudensky, A. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2019.09.010 · Cited by 154
Self-citationPediatrics Consequences of Caesarean Section—A Systematic Review and Meta-Analysis
Słabuszewska-Jóźwiak, A., Szymański, J. K., Ciebiera, M., Sarecka‐Hujar, B., & Jakiel, G. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17218031 · Cited by 162
Effects of short chain fatty acids on metabolic and inflammatory processes in human health
Campos-Perez, W. Y., & Martínez‐López, E. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2021.158900 · Cited by 157
Impact of Microbial Metabolites on Microbiota–Gut–Brain Axis in Inflammatory Bowel Disease
Banfi, D., Moro, E., Bosi, A., Bistoletti, M., Cerantola, S., Crema, F., Maggi, F., Giron, M. C., Giaroni, C., & Baj, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041623 · Cited by 160
Uchimura, Y., Fuhrer, T., Li, H., Lawson, M. A., Zimmermann, M., Yilmaz, B., Zindel, J., Ronchi, F., Sorribas, M., Hapfelmeier, S., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.08.004 · Cited by 153
Vijay-Kumar, M., Chassaing, B., Kumar, M., Baker, M. T., & Singh, V. K. (2014) · Biomedical Journal · doi:10.4103/2319-4170.130922 · Cited by 166
Schilderink, R., Verseijden, C., Seppen, J., Muncan, V., van den Brink, G. R., Lambers, T. T., van Tol, E. A. F., & de Jonge, W. J. (2016) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00411.2015 · Cited by 154
Role of diet and gut microbiota on colorectal cancer immunomodulation
Almeida, C. V. D., de Camargo, M. R., Russo, E., & Amedei, A. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i2.151 · Cited by 160
Short-chain fatty acids-producing probiotics: A novel source of psychobiotics
Cheng, Y., Liu, J., & Ling, Z. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1920884 · Cited by 156
Towards modulating the gut microbiota to enhance the efficacy of immune-checkpoint inhibitors
Simpson, R. C., Shanahan, E. R., Scolyer, R. A., & Long, G. V. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00803-9 · Cited by 153
Allen, J. M., Mailing, L. J., Cohrs, J., Salmonson, C., Fryer, J. D., Nehra, V., Hale, V. L., Kashyap, P., White, B. A., & Woods, J. A. (2018) · Gut Microbes · doi:10.1080/19490976.2017.1372077 · Cited by 152
Microbial view of central nervous system autoimmunity
Berer, K., & Krishnamoorthy, G. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.04.007 · Cited by 153
Effects of Fish n-3 PUFAs on Intestinal Microbiota and Immune System
Parolini, C. (2019) · Marine Drugs · doi:10.3390/md17060374 · Cited by 158
Deconstructing Mechanisms of Diet-Microbiome-Immune Interactions
Alexander, M., & Turnbaugh, P. J. (2020) · Immunity · doi:10.1016/j.immuni.2020.07.015 · Cited by 151
Doroszkiewicz, J., Groblewska, M., & Mroczko, B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221810028 · Cited by 166
Nutritional regulation of microbiota-derived metabolites: Implications for immunity and inflammation
Arifuzzaman, M., Collins, N., Guo, C., & Artis, D. (2024) · Immunity · doi:10.1016/j.immuni.2023.12.009 · Cited by 159
Pan, X., Fang, X., Wang, F., Li, H., Niu, W., Liang, W., Wu, C., Li, J., Tu, X., Pan, L., et al. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14806 · Cited by 151
Hu, M., Eviston, D. P., Hsu, P. S., Mariño, E., Chidgey, A. P., Santner‐Nanan, B., Wong, K., Richards, J. L., Yap, Y. A., Collier, F., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10703-1 · Cited by 155
Helicobacter species are potent drivers of colonic T cell responses in homeostasis and inflammation
Chai, J. N., Peng, Y., Rengarajan, S., Solomon, B. D., Ai, T. L., Shen, Z., Perry, J. S. A., Knoop, K. A., Tanoue, T., Narushima, S., et al. (2017) · Science Immunology · doi:10.1126/sciimmunol.aal5068 · Cited by 152
Perinatal Interactions between the Microbiome, Immunity, and Neurodevelopment
Pronovost, G. N., & Hsiao, E. Y. (2019) · Immunity · doi:10.1016/j.immuni.2018.11.016 · Cited by 150
Toward Understanding Microbiome-Neuronal Signaling
Jameson, K. G., Olson, C. A., Kazmi, S. A., & Hsiao, E. Y. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.03.006 · Cited by 155
Analysis of the gut microbiome in dogs and cats
Suchodolski, J. S. (2021) · Veterinary Clinical Pathology · doi:10.1111/vcp.13031 · Cited by 179
Fung, T. C., Bessman, N. J., Hepworth, M. R., Kumar, N., Shibata, N., Kobuley, D. E., Wang, K., Ziegler, C. G. K., Goc, J., Shima, T., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.02.019 · Cited by 148
Environmental factors in autoimmune diseases and their role in multiple sclerosis
Haase, S., Grohme, D. A., Erzler, M., Binsfeld, M., Haghikia, A., Müller, D. N., Linker, R. A., & Kleinewietfeld, M. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2311-1 · Cited by 156
Fatty acid metabolism in CD 8 + T cell memory: Challenging current concepts
Raud, B., McGuire, P. J., Jones, R. G., Sparwasser, T. D., & Berod, L. (2018) · Immunological Reviews · doi:10.1111/imr.12655 · Cited by 155
T-Cell-Driven Inflammation as a Mediator of the Gut-Brain Axis Involved in Parkinson's Disease
Campos‐Acuña, J., Elgueta, D., & Pacheco, R. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00239 · Cited by 150
Johnson, B. M., Gaudreau, M., Gadban, M. M. A., Gudi, R. R., & Vasu, C. (2015) · Clinical & Experimental Immunology · doi:10.1111/cei.12609 · Cited by 144
Rapid and Efficient Generation of Regulatory T Cells to Commensal Antigens in the Periphery
Nutsch, K., Chai, J. N., Ai, T. L., Russler-Germain, E. V., Feehley, T., Nagler‐Anderson, C., & Hsieh, C. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.08.092 · Cited by 151
Histone deacetylase function in CD4+ T cells
Ellmeier, W., & Seiser, C. (2018) · Nature reviews. Immunology · doi:10.1038/s41577-018-0037-z · Cited by 146
Cross talk between neutrophils and the microbiota
Zhang, D., & Frenette, P. S. (2019) · Blood · doi:10.1182/blood-2018-11-844555 · Cited by 153
Cait, A., Cardenas, E., Dimitriu, P. A., Amenyogbe, N., Dai, D. L., Cait, J., Sbihi, H., Stiemsma, L. T., Subbarao, P., Mandhane, P. J., et al. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2019.06.029 · Cited by 149
Tissue-specific Tregs in cancer metastasis: opportunities for precision immunotherapy
Huppert, L. A., Green, M. D., Kim, L., Chow, C., Leyfman, Y., DAUD, A. I., & Lee, J. (2021) · Cellular and Molecular Immunology · doi:10.1038/s41423-021-00742-4 · Cited by 150
The mucosal immune system for vaccine development
Lamichhane, A., Azegami, T., & Kiyono, H. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.08.089 · Cited by 153
Gordon, S. (2015) · ALTEX · doi:10.14573/altex.1510051 · Cited by 145
Vieira, A. T., Rocha, V. M., Tavares, L. P., Garcia, C. C., Teixeira, M. M., Oliveira, S. C., Cassali, G. D., Gamba, C. D. O., Martins, F. S., & Nicoli, J. R. (2015) · Microbes and Infection · doi:10.1016/j.micinf.2015.10.008 · Cited by 152
Gut dysbiosis: Ecological causes and causative effects on human disease
Winter, S., & Bäumler, A. J. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2316579120 · Cited by 160
Enteric nervous system: the bridge between the gut microbiota and neurological disorders
Geng, Z.-H., Zhu, Y., Li, Q.-L., Zhao, C., & Zhou, P.-H. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.810483 · Cited by 144
Zhu, C., Song, K., Shen, Z., Quan, Y., Tan, B., Luo, W., Wu, S., Tang, K., Yang, Z., & Wang, X. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.8833 · Cited by 144
Systemic Immunometabolism: Challenges and Opportunities
Lercher, A., Baazim, H., & Bergthaler, A. (2020) · Immunity · doi:10.1016/j.immuni.2020.08.012 · Cited by 144
Modoux, M., Rolhion, N., Lefèvre, J. H., Oeuvray, C., Nádvorník, P., Illéš, P., Emond, P., Parc, Y. R., Mani, S., Dvořák, Z., et al. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2105637 · Cited by 147
The gut–airway microbiome axis in health and respiratory diseases
Özçam, M., & Lynch, S. V. (2024) · Nature Reviews Microbiology · doi:10.1038/s41579-024-01048-8 · Cited by 164
Barrio, C., Arias-Sánchez, S., & Martín-Monzón, I. (2022) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2021.105640 · Cited by 143
Hurst, N. R., Kendig, D. M., Murthy, K. S., & Grider, J. R. (2014) · Neurogastroenterology & Motility · doi:10.1111/nmo.12425 · Cited by 147
Induction of regulatory T cells: A role for probiotics and prebiotics to suppress autoimmunity
Dwivedi, M., Kumar, P., Laddha, N. C., & Kemp, E. H. (2016) · Autoimmunity Reviews · doi:10.1016/j.autrev.2016.01.002 · Cited by 145
Impact of prebiotics on immune response: from the bench to the clinic
Pujari, R., & Banerjee, G. (2020) · Immunology and Cell Biology · doi:10.1111/imcb.12409 · Cited by 154
The microbiome–systemic diseases connection
van der Meulen, T. A., Harmsen, H., Bootsma, H., Spijkervet, F., Kroese, F., & Vissink, A. (2016) · Oral Diseases · doi:10.1111/odi.12472 · Cited by 144
Regulation of Innate and Adaptive Immunity by TGFβ
Kelly, A., Houston, S. A., Sherwood, E., Casulli, J., & Travis, M. A. (2017) · Advances in immunology · doi:10.1016/bs.ai.2017.01.001 · Cited by 145
Daïen, C., Pinget, G. V., Tan, J. K., & Macia, L. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00548 · Cited by 147
Epigenetic mechanisms regulating T-cell responses
Schmidl, C., Delacher, M., Huehn, J., & Feuerer, M. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.07.014 · Cited by 153
Mitochondria, the gut microbiome and ROS
Ballard, J. W. O., & Towarnicki, S. G. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109737 · Cited by 146
Haak, B. W., Westendorp, W. F., van Engelen, T. S. R., Brands, X., Brouwer, M. C., Vermeij, J., Hugenholtz, F., Verhoeven, A., Derks, R. J. E., Giera, M. A., et al. (2020) · Translational Stroke Research · doi:10.1007/s12975-020-00863-4 · Cited by 146
Potential Benefits of Probiotics and Prebiotics for Coronary Heart Disease and Stroke
Wu, H., & Chiou, J. A. (2021) · Nutrients · doi:10.3390/nu13082878 · Cited by 153
Gut OncoMicrobiome Signatures (GOMS) as next-generation biomarkers for cancer immunotherapy
Thomas, A. M., Fidelle, M., Routy, B., Kroemer, G., Wargo, J. A., Segata, N., & Zitvogel, L. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00785-8 · Cited by 141
Metadata
- Authors
- Arpaia, N., Campbell, C., Fan, X., Dikiy, S., van der Veeken, J., deRoos, P., Liu, H., Cross, J. R., Pfeffer, K., Coffer, P. J., & Rudensky, A. Y.
- Affiliations
- Memorial Sloan Kettering Cancer Center (US)
- Heinrich Heine University Düsseldorf (DE)
- Corresponding author
- Rudensky, Alexander Y.
- ORCID
- Venue
- Nature
- Published
- 2013-11-13
- Volume
- 504
- Issue
- 7480
- Pages
- 451-455
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3869884
- OpenAlex
- W2003342633
- Cited by
- 4,838
- References
- 25
- Citations by year
- 2026: 462 · 2025: 488 · 2024: 468 · 2023: 498 · 2022: 468 · 2021: 519 · 2020: 400 · 2019: 365 · 2018: 303 · 2017: 264 · 2016: 249 · 2015: 185 · 2014: 161 · 2013: 3
- FWCI
- 89.22
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- U.S. Public Health Service (T32A1007621)
- National Cancer Institute (T32CA009149, P30CA008748)
- National Institute of General Medical Sciences (T32GM007739)
- National Institute of Allergy and Infectious Diseases (R37AI034206, T32AI007621)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › IL-33, ST2, and ILC Pathways
- Keywords
- short-chain fatty acids, regulatory T cells, Foxp3, commensal bacteria, gut microbiota, colitis, histone H3 acetylation, colonic mucosa, intestinal immune homeostasis, Clostridia, Th17 cells, microbial metabolites
- MeSH terms
- Acetylation, Animals, Butyrates, Cell Differentiation, Dendritic Cells, Enhancer Elements, Genetic, Fermentation, Histone Deacetylases, Intestinal Mucosa, Intestines, Introns, Male, Mice, Inbred C57BL, Starch, Symbiosis, Cytokines, Lymphocyte Count, Inflammation Mediators, T-Lymphocytes, Regulatory, Mice, Forkhead Transcription Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
